Unlock instant, AI-driven research and patent intelligence for your innovation.

Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

a technology of chimeric antigen receptors and t-cells, which is applied in the field of protein evolution to achieve the effect of enhancing the wellness of a human

Inactive Publication Date: 2017-09-14
BIOATLA LLC
View PDF5 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The term "amplification" in this patent text refers to the process of making multiple copies of a piece of DNA or RNA. This can be useful in conducting research and development on the polynucleotide.

Problems solved by technology

However, engineering or evolving a protein to be inactive or virtually inactive (less than 10% activity and preferably less than 1% activity) at a wild type operating condition, while maintaining activity equivalent or better than its corresponding wild type protein at a condition other than a wild-type operating condition, requires that destabilizing mutation(s) co-exist with activity increasing mutations that do not counter the destabilizing effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
  • Conditionally Active Chimeric Antigen Receptors for Modified T-Cells
  • Conditionally Active Chimeric Antigen Receptors for Modified T-Cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

escription of a Multiwall Assay (for Example, 96-Well Assay) for Temperature Mutants

[0344]Fluorescent substrate is added to each well of a multiwall plate, at both wild-type and new, lower reaction temperatures (for example, either 37° C. or 25° C. as mentioned above) for an appropriate time period. Fluorescence is detected by measuring fluorescence in a fluorescent plate reader at appropriate excitation and emission spectra (for example, 320 nm excitation / 405 nm emission). Relative fluorescence units (RFU) are determined. Supernatant from wild type molecule and plasmid / vector transformed cells are used as positive and negative controls. Duplicate reactions are performed for each sample, reaction temperature, and positive and negative control.

[0345]Mutants that are active at the lower temperature (for example, the mutants active at 25° C.) and that have a decrease in activity at the wild type temperature (for example, a 10%, 20%, 30%, 40% or more decrease in activity at 37° C.), thu...

example 2

escription of a Different Assay Format for Confirmation of Activity (for Example, a 14-mL Assay) for Temperature Mutants

[0346]Mutants that are identified as temperature sensitive primary hits are expressed in 14 ml culture tubes and their enzymatic activity is measured at wild type (for example, 37° C.) and the lower temperature (for example, 25° C.). Protein is expressed and purified as described above for the multiwall format, with the exception that the expression is performed in different format (14 ml tubes) rather than the multiwall (96-well plate) format.

[0347]Each mutant supernatant is transferred to a multiwall plate, for example a 96-well microplate. Fluorescent substrate is added to each tube at the indicated reaction temperatures (wild-type, lower temperature) for a required period of time. Wild-type molecules are used as a positive control and supernatant from cells transformed with only vector is used as a negative control. Fluorescence is detected by measuring fluores...

example 3

escription of Further Evolution of Hits Discovered

[0350]If desired, a new, combinatorial variant library is generated from all or selected mutant hits previously identified. The new library can be designed to contain every possible combination of amino acid variants for each of the selected mutants, and rescreened as described for new hits.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
concentrationaaaaaaaaaa
temperaturesaaaaaaaaaa
Login to View More

Abstract

This disclosure relates to a chimeric antigen receptor for binding with a target antigen. The chimeric antigen receptor comprises at least one antigen specific targeting region evolved from a wild-type protein or a domain thereof and having at least one of: (a) a decrease in activity in the assay at the normal physiological condition compared to the antigen specific targeting region of the wild-type protein or a domain thereof, and (b) an increase in activity in the assay under the aberrant condition compared to the antigen specific targeting region of the wild-type protein or a domain thereof. A method for generating the chimeric antigen receptor and cytotoxic cells that express the chimeric antigen receptor are also provided.

Description

RELATED APPLICATION DATA[0001]This application claims priority to International Application No. PCT / US15 / 47197, filed Aug. 27, 2015, and U.S. Provisional Application No. 62 / 043,067, filed Aug. 28, 2014, the entire disclosure of which is hereby incorporated by reference as if set forth fully herein.FIELD OF THE DISCLOSURE[0002]This disclosure relates to the field of protein evolution. Specifically, this disclosure relates to a method of generating a conditionally active chimeric antigen receptor from a wild type protein. The conditionally active chimeric antigen receptor is reversibly or irreversibly inactivated at a wild type normal physiological condition, but is active at an aberrant condition.BACKGROUND OF THE DISCLOSURE[0003]There is a considerable body of literature describing the potential for evolving proteins for a variety of characteristics, especially enzymes. For example, enzymes may be evolved to be stabilized for operation at different conditions such as at an elevated ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K16/18A61K35/17
CPCC07K16/18C07K2319/03A61K35/17C07K14/705C07K2317/622C07K14/70503C07K14/7051C07K14/70521C07K14/70535A61K38/00A61P35/00A61P35/02A61P35/04A61K39/4644A61K39/4611A61K39/4631C12N5/0636C12N2510/00C07K16/2863A61K39/464403C07K2319/02C07K19/00C12N15/1058C12N15/102A61K39/3955A61K39/39558C07K2317/31C07K2317/92C07K2317/94A61K2039/5156A61K2039/572A61K39/395C07K16/28
Inventor SHORT, JAY M.
Owner BIOATLA LLC